Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer
Article 2016 en
Authors
TS
Toshiharu Sakurai
HK
Hiroshi Kashida
YK
Yoriaki Komeda
Abstract
1 min read
Our findings indicated that RBM3 was required for efficient inflammatory carcinogenesis in the murine CAC model and suggested that RBM3 could be a predictive biomarker of CAC risk and a new therapeutic target for cancer prevention in patients with IBD.
Discussion(0)
No comments yet. Be the first to comment.